Brown Rudnick advised Aerovate Therapeutics Inc. on the deal. Aerovate Therapeutics, Inc. (Nasdaq: AVTE), a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve...
You must be a Standard 1 Year member to access this content.
Brown Rudnick LLP advised Eliem Therapeutics on the deal. Eliem Therapeutics Inc. recently closed on a $60-million Series B financing. Eliem is a clinical-stage biotechnology company...
You must be a Standard 1 Year member to access this content.
Brown Rudnick LLP advised Westlake Village BioPartners on the deal. Westlake Village BioPartners announced a Series A investment in Capsida Biotherapeutics Inc., a biotechnology company creating a...
You must be a Standard 1 Year member to access this content.
Brown Rudnick LLP advised the lead investors RA Capital Management and Rock Springs Capital Management on the deal. RA Capital Management and Rock Springs Capital Management...
You must be a Standard 1 Year member to access this content.
Brown Rudnick LLP advised lead investor Casdin Capital and a syndicate of new investors, while White & Case LLP advised Qatar Investment Authority on the deal....
You must be a Standard 1 Year member to access this content.
